Skip to main content

Advertisement

  • Research
  • Open Access
  • Open Peer Review

Persistent organic pollutants and mortality in the United States, NHANES 1999–2011

Environmental Health201716:105

https://doi.org/10.1186/s12940-017-0313-6

©  The Author(s). 2017

  • Received: 2 May 2017
  • Accepted: 2 October 2017
  • Published:
Open Peer Review reports

Abstract

Background

Persistent organic pollutants (POPs) are environmentally and biologically persistent chemicals that include polybrominated diphenyl ethers (PBDEs), per- and polyfluoroalkyl substances (PFASs), polychlorinated biphenyls (PCBs), and organochlorine (OC) pesticides. Currently, data on the associations between exposure to POPs and the risk of mortality in the U.S. population is limited.

Our objective was to determine if higher exposure to POPs is associated with greater risk of all-cause, cancer, heart/cerebrovascular disease, or other-cause mortality.

Methods

Analyses included participants aged 60 years and older from the 1999–2006 National Health and Nutrition Examination Surveys (NHANES). We included 483 participants for analyses of PBDEs, 1043 for PFASs, and 461 for PCBs, and 1428 for OC pesticides. Exposures to POPs were estimated using biomarkers measured in serum. Mortality status through December 31, 2011 was obtained from public-use, linked mortality files. We used Cox proportional hazard models to quantify the associations of interest. Where we observed an association, we explored effect modification by sex, body mass index, smoking status, and albuminuria. We also explored the combined effect of PBDEs and OC pesticides in the subsample of participants with measures of both analytes.

Results

Serum measurements of PBDEs, PFASs, and PCBs were not clearly associated with increased all-cause or cause-specific mortality in older Americans. Beta-hexachlorocyclohexane was associated with an increased risk of all-cause mortality [HR per 1 SD increase =1.18, 95% CI = 1.01, 1.38]. Oxychlordane [HR = 1.15 95% CI 1.06, 1.25], p,p’-DDE [HR = 1.12, 95% CI = 1.02, 1.23], trans-nonachlor [HR = 1.11, 95% CI = 1.04, 1.18], and beta-hexachlorocyclohexane [HR = 1.25, 95% CI = 1.03, 1.52] were associated with increased risk of other-cause mortality. Exploratory analyses suggested associations between OC pesticides and other-cause mortality were modified by sex. Exploratory analyses also suggested that the combination of high PBDE and high OC pesticide exposure had a stronger than expected adverse effect on all-cause mortality.

Conclusion

Higher exposure to beta-hexachlorocyclohexane, an OC pesticide, is associated with increased all-cause mortality and higher exposure to four OC pesticides is associated with increased non-cancer, non-heart/cerebrovascular disease mortality in U.S. adults 60 years or older. These associations may be modified by sex or exposure to other POPs.

Keywords

  • Persistent organic pollutants
  • Mortality
  • Flame retardants
  • Organochlorine pesticides
  • Polybrominated diphenyl ethers
  • PBDEs
  • Per- and polyfluoroalkyl substances
  • PFASs
  • Polychlorinated biphenyls
  • PCBs

Background

Persistent organic pollutants (POPs) are chemicals that include polybrominated diphenyl ethers (PBDEs), per- and polyfluoroalkyl substances (PFASs), polychlorinated biphenyls (PCBs), and organochlorine (OC) pesticides. POPs persist environmentally and biologically and often bioaccumulate [1–5]; thus low-level exposure is widespread despite cessation or restrictions on manufacture and use, and POPs continue to be detectable in a large portion of the U.S population [6, 7]. However, we know relatively little about the health effects of exposure to these compounds, including their impact on mortality. Considering the prevalence, persistence, and bioaccumulation of POPs, an association with mortality in the U.S. population would have significant public health implications.

PBDEs are mixtures of chemicals that have been used as flame-retardants in many consumer products such as upholstery, plastics, and cabinets [3, 8]. Exposure to PBDEs often occur through ingesting contaminated dust, food, and breastmilk; touching contaminated soil or commercial products; and inhaling contaminated air [9, 10]. Some studies have suggested that exposure to PBDEs is associated with changes to neurodevelopment [11, 12], however, our understanding of the human health effects due to exposure is limited. To date, we are unaware of any studies assessing the association between PBDEs and mortality in the general population.

PFASs consist of a group of manufactured chemicals that repel water and oil, making them resistant to stains [4, 13]. Because of this characteristic, PFASs have been used for consumer products such as cookware, sofas, carpets, clothing, food packaging, paints, and cleaning products [4, 13]. Thus, exposure to PFASs can occur through contact with products treated with PFASs; contact with contaminated water, soil, and outdoor air near the industrial sites that manufacture or use PFASs; and consumption of contaminated food [14–17]. As with PBDEs, questions about the health effects related to exposure of PFASs at the levels that are normally found in the environment remain. Although existing studies often report conflicting findings, PFASs have been reported to increase cholesterol [18, 19] and risk of cancer [20], affect the immune system [21, 22], and decrease fertility [23]. However, as with PBDEs, whether non-occupational exposure to PFASs increases morality risk is unknown.

PCBs include manufactured mixtures of chlorinated compounds that were used as lubricants and coolants in electrical equipment, as well as other industrial applications such as plasticizers and pigments [1, 24]. The production of PCBs in the U.S. ended in 1979 because of their persistence in the environment and concern about potential health effects [24] and many countries worldwide eliminated the production and use of PCBs in 2004, in accordance with the Stockholm Convention [25]. However, because PCBs persist in the environment for many years, exposure to PCBs persists through use of contaminated electronic equipment and consumption of contaminated soil, air, water, food, and breastmilk [1, 26–28]. Increasing evidence suggests that low-level exposure to PCBs may have adverse health consequences [29–32] and the Environmental Protection Agency (EPA) has classified PCBs as probable human carcinogens [24]; however, whether PCB exposure increase risk of mortality in the general population remains uncertain. Two prior studies have used NHANES data to analyze associations of PCBs with mortality in the general population, however, they were limited by relatively short follow-up times and the omission of considering education or other measures of socioeconomic status as potential confounders [33, 34].

Finally, OC pesticides are a class of pesticides that were used because of their effectiveness against a wide variety of insects. OC pesticides that were once in common use include dichlorodiphenyltrichloroethane (DDT), oxychlordane, dieldrin, hexachlorobenzene, hexachlorocyclohexanes, and trans-nonachlor [26]. Due to their persistence in the environment and evidence of health effects, the EPA has restricted or cancelled the use of many OC pesticides [26]. Additionally, the Stockholm Convention eliminated or restricted the use of many OC pesticides throughout the world in 2004 [25]. However, these compounds continue to persist in the environment and DDT is still in use in malaria-afflicted areas. Thus, exposure to OC pesticides can occur through consumption of contaminated food, water and breastmilk; presence during application or manufacture; and touching or ingesting contaminated soil [35, 36]. Hexachlorocyclohexanes, hexachlorobenzene, heptachlor, DDT, and dichlorodiphenyldichloroethylene (DDE)—a metabolite of DDT—are classified by the EPA as probable human carcinogenic agents [37–40]. One prior study using NHANES data to assess the association between OC pesticide exposures and mortality in the general population found no significant overall association [34]. However, this study was limited by a relatively short follow-up time and the omission of education or other measures of socioeconomic status as covariates [41].

Given the sparsity of data on the associations between POPs and mortality, our objective was to determine if higher exposure to POPs—including individual PFASs, OC pesticides, and individual or summary measures of non-dioxin-like PCBs, dioxin-like PCBs, and PBDEs—are associated with greater risk of mortality in persons aged 60 years and older. We hypothesized that higher exposure to POPs increases the risk of mortality in persons aged 60 years and older.

Methods

Study population

NHANES is conducted by the National Center for Health Statistics (NCHS) to evaluate the health and nutritional status of adults and children in the United States. NHANES represents all noninstitutionalized civilians living within the United States and utilizes a complex, four-stage sample design [42]. Annually, NHANES collects data from approximately 5000 participants; data collected includes household interviews, physical examinations, and biological specimens for laboratory tests [42]. The laboratory tests are conducted on smaller, nationally representative subsamples of individuals from the total examined study population to reduce respondent burden and aid in the completion of exams [43]. The subsamples that are used for laboratory tests maintain the representative design of the survey because the subsamples are chosen at random [43]. Additional details are publicly available at: www.cdc.gov/nchs/nhanes. Our study used NHANES data for the survey periods of 1999–2006 to determine exposure levels and status of covariates. Different POPs were measured in different subsamples of survey cycles. Therefore, our study used data from 4 different subsamples with POPs measurements: OC pesticides from the 1999–2004 cycles, PBDEs and PCBs from the 2003–2004 cycle, and PFASs from the 2003–2006 cycles.

Measurement of POP concentrations

The NHANES laboratory measured PBDE analytes in serum by performing solid phase extraction and isotope dilution gas chromatography high-resolution mass spectrometry (GC/IDHRMS), while PCB and OC pesticide analytes in serum were measured by high-resolution gas chromatography/isotope-dilution high-resolution mass spectrometry (HRGC/ID-HRMS); PFAS analytes were measured by using solid phase extraction-high performance liquid chromatography-turboionspray ionization-tandem mass spectrometry (SPE-HPLC-TCI-MS/MS). Details of the laboratory methods are publicly available at: https://wwwn.cdc.gov/nchs/nhanes/. We used the value of limit of detection (LOD)/√2 for all analyte measures that resulted in report of concentrations below the LOD. Additionally, we used the lipid-adjusted concentrations for analyses of PBDEs, OC pesticides, and PCBs in our primary analyses. To address the possibility of potentially influential outliers in our relatively small samples, we natural log transformed each exposure to normalize the distribution. We then applied the Extreme Studentized Deviate Multiple Outlier Procedure to identify and exclude outliers a priori [44]. This process resulted in the identification and exclusion of 11 observations from perfluorooctanoic acid (PFOA) measures, 7 from perfluorooctane sulfonic acid (PFOS) measures, 2 from trans-nonachlor measures, 5 from p,p’-DDE measures, 4 from oxychlordane measures, and 3 from β-hexachlorocyclohexane measures. After outlier removal, we standardized all analyte concentrations by subtracting the sample mean and dividing by the standard deviation.

Mortality outcomes

We determined mortality status using the NCHS 2011 Public-use Linked Mortality Files. The length of follow-up time for each participant was determined using the NHANES study examination date and date of death, if dead, or end of follow-up, December 31, 2011. The cause of death coding follows the 10th revision of the International Statistical Classification of Diseases (ICD-10) [45]. For analyses, we categorized mortality as either all-cause, cancer (ICD codes: C00-C97), heart or cerebrovascular diseases (CBVD) (ICD codes: I00-I09, I11, I13, I20-I51, I60-I69), or other-cause (non-cancer, non-heart/cerebrovascular disease) [45].

Statistical analyses

We included participants in our analysis if they were 60 years of age or older at the time of the NHANES interview. We excluded participants from analysis if all exposure analyte measurements were missing or if they were missing data on any of the following covariates included in our primary analyses: age, gender, race/ethnicity, education, or smoking status. Given the larger number of participants missing values for body mass index (BMI), family poverty income ratio (PIR), or alcohol consumption, we filled in missing values using mode single imputation for these three covariates, which are used in sensitivity analyses.

For PBDEs, we excluded a total of 52 participants (9.6%) for missing all PBDE analyte measures. We excluded an additional 4 (0.07%) participants for missing covariate data; thus, we included a total of 483 PBDE observations for analysis. Out of a total of 11 PBDE analytes, we analyzed the association between PBDE concentrations and mortality only for the 4 analytes that were above the LOD in greater than 90% of the sample: 2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153); 2,2′,4,4′,6-pentabromodiphenyl ether (PBDE-100); 2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47); and 2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153). Additionally, we created summary measures of all PBDE concentrations (ng/g), as well as a sum for the 4 PDBE analytes (ng/g) detectable in >90% of the sample by summing the concentrations for the observations that had all PDBE analyte data available (i.e., participants with measurements below LOD were included, however those with no measurement data reported were excluded).

For PFASs, we excluded a total of 71 participants (6.4%) for missing all PFAS analyte measures; we removed an additional 4 participants (0.4%) from analysis due to missing covariate data. After exclusions, there was a total of 1043 observations for PFAS analyte analysis. Out of the 12 PFAS analytes, we analyzed associations between PFAS concentrations and mortality for those 4 individual PFASs detected in greater than 90% of the population: PFOA, PFOS, perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA).

We excluded 94 participants (16.8%) for missing all PCB analyte measures; we excluded an additional 3 observations (0.5%) due to covariate data missing. The resulting population used for analysis included 461 observations. Instead of analyzing the individual PCB analytes (29 dioxin-like and 26 non-dioxin-like), we considered six summary measures: (1) exposure to all dioxin-like PCBs, (2) exposure to dioxin-like PCBs with concentrations above the LOD in more than 90% of the population, (3) exposure to all non-dioxin-like PCBs, (4) exposure to non-dioxin-like PCB concentrations above the LOD in more than 90% of the population, (5) toxicity of exposure to dioxin-like PCBs based on toxic equivalency values (TEQs), and (6) toxicity of exposure to dioxin-like PCBs measured above the LOD in greater than 90% of the population based on TEQs. Similar to the PBDE summary measures, participants with measurements below LOD were included; however, those with no measurement data on any component PCB were excluded. For dioxin-like PCBs, TEQs were calculated using the 2005 WHO toxic equivalency factors (TEFs) [46]. The serum concentrations of the dioxin-like PCBs were multiplied by their respective TEF and then summed.

For OC pesticides, we excluded a total of 107 participants (6.9%) because all analyte data was missing. We removed an additional 6 participants (0.4%) due to missing covariate resulting in 1428 eligible participants. Out of a total of 13 OC pesticide analytes, only those 4 with measurements above the LOD in greater than 90% of the population were considered for analyses for associations with mortality: Trans-nonachlor; p,p’-DDE; Oxychlordane; and β-hexachlorocyclohexane.

We assessed the associations between the analyte exposures described above and mortality by using Cox proportional hazard models. We considered the complex survey design in analyses by using the appropriate subsample weights, stratum, and primary sampling units per NHANES recommendation. For our primary analyses, we adjusted for age, gender, race/ethnicity, education and smoking. In sensitivity analyses we also considered two additional levels of adjustment: age-adjusted and adjusted for all the covariates in our primary model plus BMI, PIR, and alcohol use. Additionally, we conducted sensitivity analyses: (1) omitting survey weighting, (2) adjusting for lipids rather than using lipid-adjusted analyte value, and (3) including previously excluded potential outliers.

We also conducted exploratory analyses considering effect modification by sex (male/female), BMI (<25/≥25 kg/m2), smoking status (yes/no), and urine albumin creatinine ratio (ACR) (<30/≥30 mg/g) using a multiplicative interaction term where our primary analyses suggested presence of an association. In addition, given PBDEs and OC pesticides were analyzed in the same 1/3rd subsample in the 2003–2004 NHANES cycle, we also conducted exploratory analyses in the ~450 individuals with both measures to determine whether PBDEs and OC pesticide exposures had synergistic impact on mortality. Specifically, we dichotomized exposures for both PBDEs and each OC pesticide at the median and included both terms and their multiplicative interaction in a single model. (We were not able to conduct this analysis with combinations including PFASs or PCBS given their concentrations were measured in different subsamples.) All analyses were performed using SAS version 9.4.

Human subjects protection issues

NHANES data were previously collected with the approval of the NCHS Research Ethics Review Board and anonymized before release to the public. All participants provided informed consent [42].

Results

Among the 483 participants included for PBDE analyses, a total of 25.7% died during the follow-up; 7.1% were determined to be due to heart/cerebrovascular diseases, 6.7% due to cancer, and 11.9% due to other-causes (Table 1). In the PBDE sample, the median age at time of examination was 70.4 years and the majority of subjects were non-Hispanic white (82.2%). Slightly less than half were male (43.6%) and had some college education or above (47.1%), while slightly more than half smoked (55.5%), consumed alcohol (58.6%), or had a family PIR greater than 2.00 (61.7%). The mean measure for BMI at time of examination was 28.0 kg/m2. The median follow-up time was 6.4 years (minimum: 0.08 years, maximum: 8.9 years). The characteristics of the 1043 subjects used in analyses for PFASs, 461 for PCBs, and 1428 for OC pesticides were similar, with the exception of follow-up time and cumulative mortality, which varied based on which NHANES cycles had POPs measurements (Table 1). Unweighted characteristics of the study sample are available in Additional file 1: Table S1.
Table 1

Characteristics and outcome of adults participating in the 1999–2006 NHANES by POPs analyte sample

 

PBDEs (N = 483) NHANES 2003–2004

PFASs (N = 1043) NHANES 2003–2006

PCBs (N = 461) NHANES 2003–2004

OC pesticides (N = 1428) NHANES 1999–2004

 

Estimatea

Std. Error of Estimatea

Estimatea

Std. Error of Estimatea

Estimatea

Std. Error of Estimatea

Estimatea

Std. Error of Estimatea

Age (years), medianb

70.4

0.3

71.0

0.3

70.2

0.4

70.5

0.2

Body mass index (kg/m2), mean

28.0

0.2

28.2

0.2

28.2

0.3

28.0

0.2

Follow-Up Time (years), median

6.4

0.2

5.5

0.1

7.4

0.1

8.7

0.2

Gender, % Male

43.6%

2.1

44.5%

2.0

42.8%

2.5

43.5%

1.2

Ethnicity, %

 White, Non-Hispanic

82.2%

2.2

82.6%

2.1

82.8%

4

81.9%

1.6

 Hispanic

5.3%

2.3

5.1%

1.1

5%

1.9

6.8%

1.5

 Black, Non-Hispanic

7.6%

1.3

8%

1.1

8.5%

2.6

8.2%

1.1

 Other

4.9%

1.2

4.3%

0.9

3.7%

1.2

3.2%

0.6

Family Poverty Income Ratio, %

 Less than/equal 2

38.3%

2.7

42.7%

2.8

43.7%

4.3

46.3%

1.9

 Greater than 2

61.7%

2.7

57.3%

2.8

56.3%

4.3

53.7%

1.9

Education Level, %

 High school or less

25.8%

3.8

27.3%

2.3

30.9%

4.0

30.1%

1.7

 High school graduate/GED

27.2%

2.4

31.0%

2.1

26.3%

2.4

27.7%

1.6

 Some college or above

47.1%

4.9

41.7%

1.7

42.8%

3.9

42.2%

1.9

Smoker, % Yes

55.5%

2.2

54.5%

1.7

57.5%

3.9

55.3%

1.5

Consume Alcohol, % Yes

58.6%

4.0

65.9%

1.9

56.9%

6.2

61.7%

2.2

Mortality Status During Follow-Up, % Deceased

 All-cause

25.7%

1.8

22.2%

1.5

23.0%

2.6

34.2%

1.4

 Heart/cerebrovascular diseases

7.1%

1.1

5.7%

0.6

7.0%

1.0

7.9%

0.7

 Cancer

6.7%

1.0

4.5%

0.7

4.8%

1.5

7.9%

0.8

 Other-cause

11.9%

1.9

12.0%

1.5

11.2%

1.9

18.2%

1.4

Notes: OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs, polychlorinated biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent organic pollutants

aWeighted to consider complex survey design

b Adults 60 years or older included in study; individuals aged 85 and over were re-coded by NHANES to 85 years of age

Table 2 shows the mean serum measurements for the analyte measures used for analyses and Additional file 1: Tables S2 to S5 summarize correlations between analytes of a given POP class. Four PBDE analytes were detected above the LOD in greater than 90% of the cohort population: PBDE-153, PBDE-100, PBDE-47, and PBB-153. The two PBDE summary measures (total PBDEs and PBDEs above LOD in >90% of the sample) were highly correlated (r = 0.99, p < 0.0001). Four PFAS analytes were above the LOD in greater than 90% of the participants: PFOA, PFOS, PFHxS, and PFNA. PFAS analytes were not strongly correlated; correlation coefficients ranged from 0.22 (p < 0.0001) to 0.63 (p < 0.0001). For PCBs, correlations between each of the summary measures considering all PCBs of a given type and the corresponding summaries restricted to those detected in >90% of the sample were high (r = 0.97 or higher, all p < 0.0001). The correlations between all dioxin-like PCBs and non-dioxin-like PCBs were lower than PBDE summaries with r = 0.80 (p < 0.0001). A total of 4 OC pesticide analytes were above the LOD in greater than 90% of the study group: β-hexachlorocyclohexane; p,p’-DDE; Oxychlordane; and Trans-nonachlor. Notably, of the OC pesticides, p,p’-DDE, had a much higher mean serum concentration compared to any other analyte. The correlations between OC pesticides ranged from 0.07 (p = 0.007) to 0.86 (p < 0.0001).
Table 2

Serum concentrations of analyzed POPs in adults 60 years or older

Exposure Measure

N

Mediana

Std. Error of Median a

PBDEs (ng/g of lipid)

 Σ PBDEs

436

53.5

4.1

 Σ PBDEs above LOD in >90%

473

42.5

3.7

 2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153)

483

5.1

0.4

 2,2′,4,4′,6-pentabromodiphenyl ether (PBDE-100)

483

3.6

0.3

 2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47)

474

19.7

2.0

 2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153)

481

4.4

0.7

PFASs (ng/g)

 Perfluorooctanoic acid (PFOA)

1036

23.7

0.7

 Perfluorooctane sulfonic acid (PFOS)

1032

4.3

0.2

 Perfluorohexane sulfonic acid (PFHxS)

1043

2.0

0.1

 Perfluorononanoic acid (PFNA)

1043

1.0

0.07

PCBs (ng/g of lipid)

 Σ Dioxin-like PCBs

380

57.5

2.5

 Σ Dioxin-like PCBs above LOD in >90%

414

58.0

2.4

 Σ Non-dioxin-like PCBs

405

284.3

10.1

 Σ Non-dioxin-like PCBs above LOD in >90%

413

281.7

10.4

 Σ TEQ Dioxin-like PCBs

385

0.03

0.001

 Σ TEQ Dioxin-like PCBs above LOD in >90%

420

0.01

0.001

OC Pesticides (ng/g of lipid)

 β-hexachlorocyclohexane

1397

25.1

1.1

 p,p’-DDE

1411

666.1

33.0

 Oxychlordane

1312

29.0

0.9

 Trans-nonachlor

1404

44.8

1.7

Notes: DDE, dichlorodiphenyldichloroethylene; LOD, limit of detection; OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs, polychlorinated biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent organic pollutants; TEQ, toxic equivalency values

a weighted to consider complex survey design

Table 3 summarizes the association between a one standard deviation unit increase in serum measurements and all-cause mortality, adjusting for age, gender, race/ethnicity, education, and smoking status. Higher exposure to PBDE-153 was associated with increased risk of all-cause mortality (HR: 1.07 per 1 SD unit increase in lipid-adjusted serum concentrations, 95% CI: 1.00, 1.14). There was little evidence to support associations between PFASs, PCBs, and the other PBDE measures with all-cause mortality. While the OC pesticides appeared to be associated with increased risk of all-cause mortality, only the association between β-hexachlorocyclohexane and all-cause mortality achieved statistical significance (HR:1.18 per 1 SD unit increase in lipid-adjusted serum concentrations 95%CI:1.01, 1.38). Exposure to PBDEs, PFASs, and PCBs were not associated with cause-specific mortality (Additional file 1: Tables S6-S8); however, higher exposure to all 4 OC pesticides was associated with increased risk of other-cause, but not cardiovascular or cancer mortality (Fig. 1, Additional file 1: Table S9). The results were materially unchanged with additional adjustment (Additional file 1: Tables S6-S9) and across all sensitivity analyses (Additional file 1: Tables S10-S13), with the exception that we no longer see an association between β-hexachlorocyclohexane and either all-cause or other-cause mortality in sensitivity analyses when we do not exclude potentially influential outliers.
Table 3

Associations between a one standard deviation unit increase in serum POP measures and all-cause mortality

Exposure

N

Hazard Ratio (95% CI)a

p-valuea

PBDEs (ng/g of lipid)

 Σ PBDEs

436

1.07 (0.90, 1.27)

0.42

 Σ PBDEs above LOD in >90%

473

1.10 (0.93, 1.30)

0.24

 2,2′,4,4′,5,5′-hexabromodiphenyl ether (PBDE-153)

483

1.07 (1.00, 1.14)

0.06

 2,2′,4,4′,6-pentabromodiphenyl ether (PBDE-100)

483

1.05 (0.91, 1.23)

0.47

 2,2′,4,4′-tetrabromodiphenyl ether (PBDE-47)

474

1.10 (0.91, 1.33)

0.29

 2,2′,4,4′,5,5′-hexabromobiphenyl (PBB-153)

482

1.04 (0.89, 1.21)

0.63

PFASs (ng/g)

 Perfluorooctane sulfonic acid (PFOS)

1036

0.91 (0.80, 1.03)

0.12

 Perfluorooctanoic acid (PFOA)

1032

0.93 (0.82, 1.06)

0.27

 Perfluorononanoic acid (PFNA)

1043

0.92 (0.80, 1.07)

0.26

 Perfluorohexane sulfonic acid (PFHxS)

1043

0.88 (0.72, 1.08)

0.21

PCBs (ng/g of lipid)

 Σ Dioxin-like PCBs

380

0.94 (0.74, 1.18)

0.55

 Σ Dioxin-like PCBs above LOD in >90%

414

0.91 (0.77, 1.08)

0.27

 Σ Non-dioxin-like PCBs

405

0.94 (0.72, 1.22)

0.61

 Σ Non-dioxin-like PCBs above LOD in >90%

413

0.97 (0.76, 1.24)

0.81

 Σ TEQ Dioxin-like PCBs

385

1.01 (0.78, 1.31)

0.92

 Σ TEQ Dioxin-like PCBs above LOD in >90%

420

0.99 (0.80, 1.23)

0.92

OC Pesticides (ng/g of lipid)

 Trans-nonachlor

1404

1.05 (0.98, 1.12)

0.17

 p,p’-DDE

1411

1.07 (0.99, 1.16)

0.09

 Oxychlordane

1312

1.07 (1.00, 1.14)

0.07

 β-hexachlorocyclohexane

1397

1.18 (1.01, 1.38)

0.04

Notes: CI, confidence interval; DDE, dichlorodiphenyldichloroethylene; LOD, limit of detection; OC, organochlorine; PBDEs, polybrominated diphenyl ethers; PCBs, polychlorinated biphenyls; PFASs, per- and polyfluoroalkyl substances; POPs, persistent organic pollutants; TEQ, toxic equivalency values

a Adjusted for age, gender, race/ethnicity, education, and smoking status; materially unchanged with additional adjustment for alcohol consumption, BMI, and poverty income ratio

Fig. 1
Fig. 1

Associationsa between a one standard deviation unit increase in serum OC pesticide measures and mortality. Note: CBVD, cerebrovascular disease; DDE, dichlorodiphenyldichloroethylene; Heart, heart disease; OC, organochlorine. a Adjusted for age, gender, race/ethnicity, education, and smoking status

As we observed statistically significant main effects for β-hexachlorocyclohexane with all-cause mortality and all four OC pesticide analytes with other-cause mortality, we proceeded to explore whether sex, BMI, smoking status, or ACR modified these associations; results are summarized in Table 4. Associations were uniformly stronger among overweight individuals, although there was little statistical support for effect modification with the exception of the association between oxychlordane and other-cause mortality (p = 0.04). There was little evidence of effect modification by smoking status or ACR. Finally, the association between OC exposure and other-cause mortality was stronger in men for trans-nonachlor, p,p’-DDE, and oxychlordane, but was stronger in women for β-hexachlorocyclohexane. However, there was no support for effect modification by sex when considering the association between β-hexachlorocyclohexane and all-cause mortality.
Table 4

Summary of exploratory analyses considering effect modification by BMI, smoking status, and sex where main effects were present

Mortality/Exposure

N

Hazard Ratio (95% CI)a

p-value for interaction

Hazard Ratio (95% CI)a

p-value for interaction

  

BMI < 25

BMI ≥ 25

 

Non-Smoker

Current Smoker

 

All-Cause

 β-hexachlorocyclohexane

1397

1.06 (0.82, 1.37)

1.36 (1.15, 1.62)

0.08

1.15 (0.98, 1.34)

1.36 (1.02, 1.8)

0.24

Other-cause

 Trans-nonachlor

1404

1.07 (0.98, 1.17)

1.15 (1.06, 1.26)

0.18

1.1 (1.04, 1.16)

1.14 (0.98, 1.33)

0.59

 p,p’-DDE

1411

1.05 (0.74, 1.47)

1.13 (1.05, 1.22)

0.64

1.15 (1.05, 1.25)

1.03 (0.82, 1.3)

0.39

 Oxychlordane

1312

1.09 (0.99, 1.2)

1.25 (1.12, 1.4)

0.04

1.12 (1.04, 1.2)

1.27 (1.07, 1.51)

0.12

 β-hexachlorocyclohexane

1397

1.21 (0.96, 1.53)

1.35 (1.12, 1.63)

0.38

1.25 (1.02, 1.54)

1.3 (0.85, 1.98)

0.87

Mortality/Exposure

N

Hazard Ratio (95% CI)a

p-value for interaction

Hazard Ratio (95% CI)a

p-value for interaction

  

Female

Male

 

ACR < 30

ACR ≥ 30

 

All-Cause

 β-hexachlorocyclohexane

1397

1.22 (0.97, 1.54)

1.16 (0.96, 1.4)

0.71

1.16 (0.98, 1.39)

1.35 (1.08, 1.68)

0.30

Other-cause

 Trans-nonachlor

1404

1.07 (0.99, 1.15)

1.19 (1.07, 1.33)

0.07

1.08 (1, 1.17)

1.18 (1.01, 1.37)

0.28

 p,p’-DDE

1411

1.05 (0.9, 1.23)

1.38 (1.13, 1.69)

0.01

1.1 (0.97, 1.24)

1.17 (0.98, 1.39)

0.52

 Oxychlordane

1312

1.11 (1.02, 1.19)

1.37 (1.1, 1.7)

0.05

1.13 (1.04, 1.22)

1.18 (0.98, 1.41)

0.64

 β-hexachlorocyclohexane

1397

1.46 (1.15, 1.85)

1.11 (0.89, 1.39)

0.05

1.26 (1.01, 1.56)

1.37 (0.96, 1.96)

0.67

aWeighted to consider complex survey design, adjusted for age, gender, race/ethnicity, education, and smoking status

In exploratory analyses, there was little evidence of interaction between PBDEs and OC pesticide exposure on cancer or cardiovascular/cerebrovascular mortality. However, we did observe a marginally significant interaction between PBDEs with p,p’-DDE and oxychlordane whereby those with high exposure to both PBDEs and either OC pesticide had higher than expected other-cause mortality (Table 5). While similar trends were observed for trans-nonachlor or β-hexachlorocyclohexane there was little statistical support for effect modification in these analyses. While we observed statistically significant p-values for the interaction of PBDEs with p,p’-DDE, the pattern of association observed for all-cause mortality was not repeated. There was no statistical support for interaction with the other OC pesticides on other-cause mortality. Of note, our category-specific estimates are often imprecise given small numbers.
Table 5

Summary of exploratory analyses considering synergism of exposure to PBDEs and OC pesticides on all-cause and other-cause mortality

  

HR (95%CI)a, all-cause mortality

Σ PBDEs above LOD in >90%

HR (95%CI)a, other-cause mortality

Σ PBDEs above LOD in >90%

 
  

Less than median

Higher than median

interaction p-value

Less than median

Higher than median

interaction p-value

Trans-nonachlor

Less than median

1.0 (Ref.)

1.08 (0.58, 2.00)

0.09

1.0 (Ref.)

0.47 (0.12, 1.86)

0.24

Higher than median

1.07 (0.67, 1.70)

1.96 (1.11, 3.43)

0.95 (0.47, 1.94)

1.00 (0.52, 1.93)

p,p’-DDE

Less than median

1.0 (Ref.)

1.10 (0.63, 1.94)

0.08

1.0 (Ref.)

0.37 (0.17, 0.81)

0.01

Higher than median

0.84 (0.46, 1.54)

1.63 (1.03, 2.59)

0.93 (0.42, 2.08)

1.06 (0.46, 2.42)

Oxychlordane

Less than median

1.0 (Ref.)

0.90 (0.40, 2.04)

0.14

1.0 (Ref.)

0.88 (0.39, 1.97)

0.29

Higher than median

0.87 (0.50, 1.51)

1.60 (1.00, 2.54)

0.34 (0.05, 2.49)

0.96 (0.54, 1.70)

β-hexachlorocyclohexane

Less than median

1.0 (Ref.)

1.13 (0.61, 2.10)

0.26

1.0 (Ref.)

0.60 (0.17, 2.1)

0.49

Higher than median

0.78 (0.41, 1.48)

1.43 (0.86, 2.74)

0.78 (0.36, 1.70)

0.76 (0.37, 1.54)

aAdjusted for age, gender, race/ethnicity, education, and smoking status

Discussion

Our study found that serum measurements of PBDEs, PFASs, and PCBs are not clearly associated with increased mortality in the U.S. population aged 60 years or older. β-hexachlorocyclohexane, an OC pesticide, was associated with an increased risk of all-cause mortality. All four OC pesticides detectable in >90% of the sample (oxychlordane; p,p’-DDE; Trans-nonachlor; and β-hexachlorocyclohexane) were associated with increased risk of other-cause (non-cancer, non-cardiovascular) mortality. Exploratory analyses suggest these associations may be modified by sex, BMI, or PBDE exposures, but this requires further confirmation in an independent sample.

To our knowledge, this study was the first to examine the effects of PBDE exposures on mortality in a human sample. Prior studies of the associations between exposure to PFASs and mortality were conducted in occupational settings and report either no association or lower mortality in workers exposed to PFASs [47–50]. Our results were similar; while our point estimates suggested PFASs were associated with decreased mortality these results were not statistically significant. Multiple prior studies report elevated risk of cancer-related mortality with PCB exposure in occupational and poisoning settings, although these results are not conclusive given concerns about unclear dose-response relationships and residual confounding [51–58]. Prior studies in NHANES using summaries of PCB exposures from 1999 to 2004 report associations between total PCB exposures and excess cardiovascular mortality, but not all-cause or cancer-related mortality, among adults 70 years or older over a mean of 4.1 years of follow-up [41] and associations between higher exposure to dioxin-like compounds and all-cause mortality in adults ages 40 or older over a mean of 4.6 years of follow-up [33]. Our results conflict with these prior findings as we found no association between PCBs and all-cause or cause-specific analyses and may be related to lack of adjustment for education or other measures of socioeconomic status, shorter follow-up time, and consideration of a smaller, different set of compounds in prior studies. Finally, prior studies of occupational OC pesticide exposure and mortality generally report found lower than expected rates of all-cause mortality in exposed persons, but likely suffer from healthy-worker bias [59–61] A prior study using data from NHANES reported no association between exposure to OC pesticides and all-cause mortality, cancer mortality, or cardiovascular mortality over a mean 4.1 year follow-up period in persons 70 years and older [41], but did not consider other-cause mortality. Thus, our finding of increased risk of other-cause (non-cancer, non-cardiovascular) mortality with greater exposure OC pesticides is novel. Given the heterogeneous nature of “other-cause” mortality and the wide-ranging causes of death that are ultimately attributable to underlying diabetes or dementia, it is plausible that our results for OC pesticide exposure and other-cause mortality is due to associated increased risk of diabetes or dementia. Several recent studies have linked OC pesticide exposure to incident diabetes or markers indicative of increased risk of diabetes [62–64] as well as to elevated risk for cognitive decline or dementia [65–67].

While our report of exploratory analyses considering the combined impact of PBDEs and OC pesticides is novel, several prior studies suggest modification of the POPs-mortality association by BMI, smoking, or ACR. While not statistically significantly in our analyses, the suggestion of greater mortality among overweight and obese individuals with high OC pesticide exposure is opposite than reported previously. [41, 68] Conversely, while we did not observe significant effect modification by ACR, our point estimates were often consistent with the prior report of greater mortality among those with high ACR and high OC pesticide exposure [69] or among current smokers with high OC pesticide exposure [70]. The suggestion that sex modifies the OC pesticide other-cause mortality association is potentially plausible given potential endocrine-disruption related effects of exposure [71], but requires further confirmation in other samples.

There are limitations to our study. First, our sample size for each analysis was relatively small, due to data availability or concerns about combining multiple years of exposure data in the face of changing lists of analytes assessed in different cycles and potential time trends in exposure. This limited our ability to detect small effect and our ability to further investigate the association with more refined cause-specific mortality categories. Similarly, although motivated by evidence of effect modification in other settings [34, 68–70], we consider our analyses of effect modification to be exploratory given our small sample. Future work in larger samples will be required to examine the effect of exposure within potentially susceptible sub-populations. We also view our analyses of the combined effect of PBDEs and OC pesticides to be exploratory, and were unable to consider combined effects of multiple classes of POPs, as PCBs, PFASs, and PBDEs/OC pesticidess were measured in different subsamples. As with any epidemiologic study, we cannot definitively rule out the possibility of bias or chance. However, we adjusted our analyses for many possible confounders, minimizing the potential for residual confounding. We used a nationally-representative sample and evaluated associations with mortality, limiting the potential for selection bias. Finally, as our exposure and outcome are objective outcomes, and mortality was assessed independently of exposure status, we expect minimal impact of measurement error and that any resulting bias would be towards the null.

Our study also has strengths. The data is from NHANES and is a nationally representative study [42], thus our findings are generalizable to the older U.S. population as a whole. Several aspects of our primary analyses were novel, including examination of the association of PBDEs with mortality and consideration of associations between POPs and non-CVD, non-cancer mortality. We were able to address several of the potential limitations of the previous literature, including addressing potential confounding by education and socioeconomic status. Additionally, our study benefited from relatively long follow-up times, ranging from 9 to 13 years, which minimizes the potential impact of reverse causation, whereby impending death impacts POPs exposure levels.

Conclusions

Our study provides evidence of an adverse association between exposure to OC pesticides and non-cancer, non-heart/cerebrovascular disease mortality in adults 60 years or older in the U.S. This association may be modified by several factors, including exposure to other POPs. Additional research to confirm this finding and determine how OC pesticides may impact other-cause mortality is warranted.

Abbreviations

ACR: 

Albumin creatinine ratio

BMI: 

Body mass index

CBVD: 

Cerebrovascular diseases

DDE: 

Dichlorodiphenyldichloroethylene

DDT: 

Dichlorodiphenyltrichloroethane

LOD: 

Limit of detection

NCHS: 

National Center for Health Statistics

NHANES: 

National Health and Nutrition Examination Surveys

OC: 

Organochlorine

PBB-153: 

2,2′,4,4′,5,5′-hexabromobiphenyl

PBDE-100: 

2,2′,4,4′,6-pentabromodiphenyl ether

PBDE-153: 

2,2′,4,4′,5,5′-hexabromodiphenyl ether

PBDE-47: 

2,2′,4,4′-tetrabromodiphenyl ether

PBDEs: 

Polybrominated diphenyl ethers

PCBs: 

Polychlorinated biphenyls

PFASs: 

Per- and polyfluoroalkyl substances

PFHxS: 

Perfluorohexane sulfonic acid

PFNA: 

Perfluorononanoic acid

PFOA: 

Perfluorooctanoic acid

PFOS: 

Perfluorooctane sulfonic acid

PIR: 

Family poverty income ratio

POPs: 

Persistent organic pollutants

TEFs: 

Toxic equivalency factors

TEQs: 

Toxic equivalency values

Declarations

Acknowledgements

We thank the staff and participants of the NHANES for their contributions to this work. We report no competing financial interests.

Funding

The authors declare that the current study had no source of funding.

Availability of data and materials

The datasets generated and analyzed during the current study are available in the NHANES repository, https://wwwn.cdc.gov/nchs/nhanes/Default.aspx.

Authors’ contributions

KF analyzed and interpreted the data, and was a major contributor in writing the manuscript. MCP made substantial contributions to the concept and design, and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

NHANES data were previously collected with the approval of the NCHS Research Ethics Review Board and anonymized before release to the public. All participants provided informed consent prior to participation. Given NHANES data are anonymized and publically available, the George Washington University IRB determined that the current study did not meet the criteria for human subjects research.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Epidemiology and Biostatistics, The George Washington University, 950 New Hampshire Avenue NW, 5th Floor, Washington DC, 20052, USA

References

  1. Carpenter D. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health. 2006;21:1–23. https://doi.org/10.1515/REVEH.2006.21.1.1.View ArticleGoogle Scholar
  2. Langenbach T. Persistence and bioaccumulation of persistent organic pollutants (POPs). In: Patil YB, Rao P, editors. Applied bioremediation - active and passive approaches. Rijeka: InTech; 2013. p. Ch. 13.Google Scholar
  3. ATSDR. Public health statement for Polybrominated Diphenyl ethers (PBDEs). Department of health and human services. 2015. https://www.atsdr.cdc.gov/phs/phs.asp?id=1449&tid=183. Accessed 11 Sept 2016.
  4. ATSDR. Per- and Polyfluoroalkyl substances and your health. Department of Health and Human Service. 2016. https://www.atsdr.cdc.gov/pfc/overview.html. Accessed 11 Sept 2016.
  5. EPA. Persistent Organic Pollutants: A Global Issue, A Global Response. 2009. https://www.epa.gov/international-cooperation/persistent-organic-pollutants-global-issue-global-response. Accessed 9 Apr 2017.
  6. Sjodin A, Jones RS, Caudill SP, Wong LY, Turner WE, Calafat AM. Polybrominated diphenyl ethers, polychlorinated biphenyls, and persistent pesticides in serum from the national health and nutrition examination survey: 2003-2008. Environ Sci Technol. 2014;48(1):753–60. https://doi.org/10.1021/es4037836.View ArticleGoogle Scholar
  7. Patterson JDG, Wong L-Y, Turner WE, Caudill SP, DiPietro ES, McClure PC, et al. Levels in the U.S. population of those persistent organic pollutants (2003−2004) included in the Stockholm convention or in other long-range Transboundary air pollution agreements. Environmental Science & Technology. 2009;43(4):1211–8. https://doi.org/10.1021/es801966w.View ArticleGoogle Scholar
  8. EPA. Polybrominated Diphenyl ethers (PBDEs) action plan 2009.Google Scholar
  9. Frederiksen M, Vorkamp K, Thomsen M, Knudsen LE. Human internal and external exposure to PBDEs – a review of levels and sources. Int J Hyg Environ Health. 2009;212(2):109–34. http://dx.doi.org/10.1016/j.ijheh.2008.04.005.
  10. Wu N, Herrmann T, Paepke O, Tickner J, Hale R, Harvey E, et al. Human exposure to PBDEs: associations of PBDE body burdens with food consumption and house dust concentrations. Environmental Science & Technology. 2007;41(5):1584–9. https://doi.org/10.1021/es0620282.View ArticleGoogle Scholar
  11. Chevrier C, Warembourg C, Le Maner-Idrissi G, Lacroix A, Dardier V, Le Sourn-Bissaoui S, et al. Childhood exposure to polybrominated diphenyl ethers and neurodevelopment at six years of age. Neurotoxicology. 2016;54:81–8. https://doi.org/10.1016/j.neuro.2016.03.002.View ArticleGoogle Scholar
  12. Ding G, Yu J, Cui C, Chen L, Gao Y, Wang C, et al. Association between prenatal exposure to polybrominated diphenyl ethers and young children's neurodevelopment in China. Environ Res. 2015;142:104–11. https://doi.org/10.1016/j.envres.2015.06.008.View ArticleGoogle Scholar
  13. EPA. Basic information about per- and Polyfluoroalkyl substances (PFASs). 2016. https://www.epa.gov/pfas/basic-information-about-and-polyfluoroalkyl-substances-pfass. Accessed 9 Apr 2017.
  14. Nadal M, Domingo L, Indoor Dust J. Levels of Perfluoroalkyl substances (PFASs) and the role of ingestion as an exposure pathway: a review. Curr Org Chem. 2014;18(17):2200–8.View ArticleGoogle Scholar
  15. Domingo JL, Jogsten IE, Eriksson U, Martorell I, Perelló G, Nadal M, et al. Human dietary exposure to perfluoroalkyl substances in Catalonia, Spain. Temporal trend. Food Chem. 2012;135(3):1575–82. http://dx.doi.org/10.1016/j.foodchem.2012.06.054.
  16. Domingo JL, Nadal M. Per- and Polyfluoroalkyl substances (PFASs) in food and human dietary intake: a review of the recent scientific literature. J Agric Food Chem. 2017;65(3):533–43. doi:10.1021/acs.jafc.6b04683.View ArticleGoogle Scholar
  17. Jian J-M, Guo Y, Zeng L, Liang-Ying L, Lu X, Wang F, et al. Global distribution of perfluorochemicals (PFCs) in potential human exposure source–a review. Environ Int. 2017;108:51–62. http://dx.doi.org/10.1016/j.envint.2017.07.024.View ArticleGoogle Scholar
  18. Eriksen KT, Raaschou-Nielsen O, McLaughlin JK, Lipworth L, Tjonneland A, Overvad K, et al. Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. PLoS One. 2013;8(2):e56969. https://doi.org/10.1371/journal.pone.0056969.View ArticleGoogle Scholar
  19. Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere. 2014;98:78–83. https://doi.org/10.1016/j.chemosphere.2013.10.005.View ArticleGoogle Scholar
  20. Ghisari M, Eiberg H, Long M, Bonefeld-Jorgensen EC. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health. 2014;13(1):19. https://doi.org/10.1186/1476-069x-13-19.View ArticleGoogle Scholar
  21. Kielsen K, Shamim Z, Ryder LP, Nielsen F, Grandjean P, Budtz-Jorgensen E, et al. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol. 2016;13(2):270–3. https://doi.org/10.3109/1547691x.2015.1067259.View ArticleGoogle Scholar
  22. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307(4):391–7. https://doi.org/10.1001/jama.2011.2034.View ArticleGoogle Scholar
  23. Velez MP, Arbuckle TE, Fraser WD. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Hum Reprod. 2015;30(3):701–9. https://doi.org/10.1093/humrep/deu350.View ArticleGoogle Scholar
  24. EPA. Learn about polychlorinated biphenyls (PCBs). 2016. https://www.epa.gov/pcbs/learn-about-polychlorinated-biphenyls-pcbs. Accessed 11 Sept 2016.
  25. UNEP. Stockholm convention on persistent organic pollutants (POPs) as amended in 2009. Stockholm Convention; 2009.Google Scholar
  26. CDC. Fourth National Report on human exposure to environmental chemicals. Atlanta, GA: Centers for Disease Control and Prevention 2009.Google Scholar
  27. Xue J, Liu SV, Zartarian VG, Geller AM, Schultz BD. Analysis of NHANES measured blood PCBs in the general US population and application of SHEDS model to identify key exposure factors. Journal of exposure science & environmental epidemiology. 2014;24(6):615–21. https://doi.org/10.1038/jes.2013.91.View ArticleGoogle Scholar
  28. Fernández-González R, Yebra-Pimentel I, Martínez-Carballo E, Simal-Gándara JA. Critical review about human exposure to polychlorinated Dibenzo-p-dioxins (PCDDs), polychlorinated Dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) through foods. Crit Rev Food Sci Nutr. 2015;55(11):1590–617. https://doi.org/10.1080/10408398.2012.710279.View ArticleGoogle Scholar
  29. Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ Health Perspect. 2010;118(12):1735–42. https://doi.org/10.1289/ehp.1002720.View ArticleGoogle Scholar
  30. Eubig PA, Aguiar A, Schantz SL. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect. 2010;118(12):1654–67. https://doi.org/10.1289/ehp.0901852.View ArticleGoogle Scholar
  31. Fitzgerald EF, Belanger EE, Gomez MI, Cayo M, McCaffrey RJ, Seegal RF, et al. Polychlorinated biphenyl exposure and neuropsychological status among older residents of upper Hudson River communities. Environ Health Perspect. 2008;116(2):209–15. doi:10.1289/ehp.10432.View ArticleGoogle Scholar
  32. Stark AD, Costas K, Chang HG, Vallet HL. Health effects of low-level exposure to polychlorinated biphenyls. Environ Res. 1986;41(1):174–83.View ArticleGoogle Scholar
  33. Lin YS, Caffrey JL, Hsu PC, Chang MH, Faramawi MF, Lin JW. Environmental exposure to dioxin-like compounds and the mortality risk in the U.S. population. Int J Hyg Environ Health. 2012;215(6):541–6. doi:10.1016/j.ijheh.2012.02.006.View ArticleGoogle Scholar
  34. Kim SA, Kim KS, Lee YM, Jacobs DR, Lee DH. Associations of organochlorine pesticides and polychlorinated biphenyls with total, cardiovascular, and cancer mortality in elders with differing fat mass. Environ Res. 2015;138:1–7. doi:10.1016/j.envres.2015.01.021.View ArticleGoogle Scholar
  35. ATSDR. Public Health Statement for Hexachlorocyclohexane (HCH). Department Health and Human Services. 2005. https://www.atsdr.cdc.gov/PHS/PHS.asp?id=752&tid=138. Accessed 5 Sept 2016.
  36. Jayaraj R, Megha P, Sreedev P. Organochlorine pesticides, their toxic effects on living organisms and their fate in the environment. Interdiscip Toxicol. 2016;9(3–4):90–100. doi:10.1515/intox-2016-0012.Google Scholar
  37. EPA. Technical Hexachlorocyclohexane (t-HCH). 2016. https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=165. Accessed 9 Apr 2017.
  38. EPA. Hexachlorobenzene. 2016. https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=374. Accessed 9 Apr 2017.
  39. EPA. p,p’-Dichlorodiphenyltrichloroethane (DDT). 2016. https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=147. Accessed 9 Apr 2017.
  40. EPA. p,p’-Dichlorodiphenyldichloroethylene (DDE). 2016. https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=328. Accessed 9 Apr 2017.
  41. Kim S-A, Kim K-S, Lee Y-M, Jacobs DR, Lee D-H. Associations of organochlorine pesticides and polychlorinated biphenyls with total, cardiovascular, and cancer mortality in elders with differing fat mass. Environ Res. 2015;138:1–7. http://dx.doi.org/10.1016/j.envres.2015.01.021.
  42. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: Plan and operations, 1999-2010. Vital Health Stat 1 2013(56):1-37.Google Scholar
  43. Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al. The National Health and nutrition examination survey: sample design, 1999-2006. Vital Health Stat 2. 2012;155:1–39.Google Scholar
  44. Rosner B. On the detection of many outliers. Technometrics. 1975;17(2):221–7. https://doi.org/10.2307/1268354.View ArticleGoogle Scholar
  45. NCHS. NCHS data linked to NDI mortality files. 2016. https://www.cdc.gov/nchs/data-linkage/mortality.htm. Accessed 15 Sept 2016.
  46. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 2006;93(2):223–41. doi:10.1093/toxsci/kfl055.View ArticleGoogle Scholar
  47. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol. 2008;18(1):15–22. https://doi.org/10.1016/j.annepidem.2007.06.011.View ArticleGoogle Scholar
  48. Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med. 2003;60(10):722–9.View ArticleGoogle Scholar
  49. Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med. 1993;35(9):950–4.View ArticleGoogle Scholar
  50. Steenland K, Woskie S. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol. 2012;176(10):909–17. https://doi.org/10.1093/aje/kws171.View ArticleGoogle Scholar
  51. Ruder AM, Hein MJ, Hopf NB, Waters MA. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health. 2014;217(2–3):176–87. https://doi.org/10.1016/j.ijheh.2013.04.006.View ArticleGoogle Scholar
  52. Kimbrough RD, Krouskas CA, Xu W, Shields PG. Mortality among capacitor workers exposed to polychlorinated biphenyls (PCBs), a long-term update. Int Arch Occup Environ Health. 2015;88(1):85–101. https://doi.org/10.1007/s00420-014-0940-y.View ArticleGoogle Scholar
  53. Prince MM, Ruder AM, Hein MJ, Waters MA, Whelan EA, Nilsen N, et al. Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health Perspect. 2006;114(10):1508–14.View ArticleGoogle Scholar
  54. Li MC, Chen PC, Tsai PC, Furue M, Onozuka D, Hagihara A, et al. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a meta-analysis of two highly exposed cohorts. Int J Cancer. 2015;137(6):1427–32. https://doi.org/10.1002/ijc.29504.View ArticleGoogle Scholar
  55. Li MC, Tsai PC, Chen PC, Hsieh CJ, Leon Guo YL, Rogan WJ. Mortality after exposure to polychlorinated biphenyls and dibenzofurans: 30 years after the “Yucheng accident”. Environ Res. 2013;120:71–5. https://doi.org/10.1016/j.envres.2012.09.003.View ArticleGoogle Scholar
  56. Onozuka D, Yoshimura T, Kaneko S, Furue M. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a 40-year follow-up study of Yusho patients. Am J Epidemiol. 2009;169(1):86–95. doi:10.1093/aje/kwn295.View ArticleGoogle Scholar
  57. Gustavsson P, Hogstedt CA. Cohort study of Swedish capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Am J Ind Med. 1997;32(3):234–9.View ArticleGoogle Scholar
  58. Sinks T, Steele G, Smith AB, Watkins K, Shults RA. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol. 1992;136(4):389–98.View ArticleGoogle Scholar
  59. Brown DP. Mortality of workers employed at organochlorine pesticide manufacturing plants--an update. Scand J Work Environ Health. 1992;18(3):155–61.View ArticleGoogle Scholar
  60. Ditraglia D, Brown DP, Namekata T, Iverson N. Mortality study of workers employed at organochlorine pesticide manufacturing plants. Scand J Work Environ Health. 1981;7(Suppl 4):140–6.Google Scholar
  61. de Jong G, Swaen GM, Slangen JJ. Mortality of workers exposed to dieldrin and aldrin: a retrospective cohort study. Occup Environ Med. 1997;54(10):702–7.View ArticleGoogle Scholar
  62. Montgomery MP, Kamel F, Saldana TM, Alavanja MC, Sandler DP. Incident diabetes and pesticide exposure among licensed pesticide applicators: agricultural health study, 1993-2003. Am J Epidemiol. 2008;167(10):1235–46. doi:10.1093/aje/kwn028.View ArticleGoogle Scholar
  63. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6(1):e15977. https://doi.org/10.1371/journal.pone.0015977.View ArticleGoogle Scholar
  64. Turyk M, Fantuzzi G, Persky V, Freels S, Lambertino A, Pini M, et al. Persistent organic pollutants and biomarkers of diabetes risk in a cohort of Great Lakes sport caught fish consumers. Environ Res. 2015;140:335–44. https://doi.org/10.1016/j.envres.2015.03.037.View ArticleGoogle Scholar
  65. Kim SA, Lee YM, Lee HW, Jacobs DR, Jr., Lee DH. Greater cognitive decline with aging among elders with high serum concentrations of organochlorine pesticides. PLoS One 2015;10(6):e0130623. https://doi.org/10.1371/journal.pone.0130623.
  66. Lee DH, Lind PM, Jacobs DR Jr, Salihovic S, van Bavel B, Lind L. Association between background exposure to organochlorine pesticides and the risk of cognitive impairment: a prospective study that accounts for weight change. Environ Int. 2016;89-90:179–84. https://doi.org/10.1016/j.envint.2016.02.001.View ArticleGoogle Scholar
  67. Yan D, Zhang Y, Liu L, Yan H. Pesticide exposure and risk of Alzheimer's disease: a systematic review and meta-analysis. Sci Rep. 2016;6:32222. https://doi.org/10.1038/srep32222.View ArticleGoogle Scholar
  68. Hong NS, Kim KS, Lee IK, Lind PM, Lind L, Jacobs DR, et al. The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox. Int J Obes. 2012;36(9):1170–5. https://doi.org/10.1038/ijo.2011.187.View ArticleGoogle Scholar
  69. Kim HW, Kim JH, Lee DW, Cho SH, Jung JH, Kim KS, et al. Different associations of albuminuria with total and cardiovascular mortality by concentrations of persistent organic pollutants in the elderly. Environ Res. 2017;155:175–81. https://doi.org/10.1016/j.envres.2017.02.006.View ArticleGoogle Scholar
  70. Lee Y-M, Bae S-G, Lee S-H, Jacobs DR, Lee D-H. Associations between cigarette smoking and Total mortality differ depending on serum concentrations of persistent organic pollutants among the elderly. J Korean Med Sci. 2013;28(8):1122–8. https://doi.org/10.3346/jkms.2013.28.8.1122.View ArticleGoogle Scholar
  71. Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342. https://doi.org/10.1210/er.2009-0002.View ArticleGoogle Scholar

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement

Environmental Health

ISSN: 1476-069X